UB Paderborn / Katalog / Suche / in CDI

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

Leukemia, 2021-03, Vol.35 (3), p.835-849

2021

Volltextzugriff (PDF)

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

Leukemia, 2017-11, Vol.31 (11), p.2538-2539

2017

Volltextzugriff (PDF)

Choosing the Appropriate Denominator for Counting BM Blasts

Leukemia research, 2017-04, Vol.55, p.S4-S4

2017

Volltextzugriff (PDF)

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome

Thrombosis research, 2021-12, Vol.208, p.226-229

2021

Volltextzugriff (PDF)

Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale

Journal of geriatric oncology, 2015-09, Vol.6 (5), p.353-361

2015

Volltextzugriff (PDF)

The Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts can be Improved by Considering Bone Marrow Blasts from Nonerythroid Cells

Leukemia research, 2017-04, Vol.55, p.S135-S136

2017

Volltextzugriff (PDF)

Clinical and Biological Significance of Y Chromosome Loss in a Series of 2,423 Male Patients with MDS and CMML

Leukemia research, 2017-04, Vol.55, p.S122-S123

2017

Volltextzugriff (PDF)

Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance

Leukemia research, 2017-04, Vol.55, p.S137-S138

2017

Volltextzugriff (PDF)

Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.694-699

2012

Volltextzugriff (PDF)

260 CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS

Leukemia research, 2015-04, Vol.39, p.S130-S131

2015

Volltextzugriff (PDF)

261 ERYTHROLEUKEMIA APPEARS TO BE A CONTINUUM OF MDS WITH ERYTHROID HYPERPLASIA AND SHARES OUTCOME AND CYTOGENETIC FEATURES WITH RAEB-1 WITH ≥50% ERYTHROPOIESIS

Leukemia research, 2015-04, Vol.39, p.S131-S132

2015

Volltextzugriff (PDF)

144 CSF3R POINT MUTATIONS IN A COHORT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND NEUTROPENIA AT DIAGNOSIS

Leukemia research, 2015-04, Vol.39, p.S73-S73

2015

Volltextzugriff (PDF)

Prognostic Impact of Circulating Plasma Cells on Survival of Patients With Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e85-e85

2015

Volltextzugriff (PDF)

Smoldering Multiple Myeloma: Impact of the Evolving Pattern on Early Progression

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e92-e92

2015

Volltextzugriff (PDF)

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

The New England journal of medicine, 2016-11, Vol.375 (20), p.1946-1960

2016

Volltextzugriff (PDF)

P368 Correlation between patient-reported outcome measures in inflammatory bowel disease and other measures of disease activity: a systematic review

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i780-i781

2024

Volltextzugriff (PDF)

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

The New England journal of medicine, 2012-10, Vol.367 (16), p.1519-1528

2012

Volltextzugriff (PDF)

313 Clinical features and prognostic significance of monosomal karyotype (MK) in the myelodysplastic syndromes (MDS)

Leukemia research, 2011, Vol.35, p.S124-S125

2011

Volltextzugriff (PDF)

Validation of the ATTR-CM score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior

Haematologica (Roma), 2010-09, Vol.95 (9), p.1526-1533

2010

Volltextzugriff (PDF)

O-056 - ANÁLISIS DESCRIPTIVO DE LOS EVENTOS TROMBOEMBÓLICOS VENOSOS EN PACIENTES INGRESADOS EN NEUROCIRUGÍA DESDE EL INICIO DE LA ASISTENCIA COMPARTIDA

Neurocirugía (Asturias, Spain), 2023-05, Vol.34, p.S189-S189

2023

Volltextzugriff (PDF)

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: GENOMIC DETERMINANTS OF DYSMYELOPOIESIS AND EVALUATION OF ITS PROGNOSTIC IMPACT IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

Leukemia research, 2023-05, Vol.128, p.107231, Article 107231

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SEX DETERMINES DIFFERENTIAL GENOMIC PROFILES IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) INVOLVING UNDERREPRESENTATION OF SRSF2 GENE MUTATION

Leukemia research, 2023-05, Vol.128, p.107188, Article 107188

2023

Volltextzugriff (PDF)

8 - Choosing the Appropriate Denominator for Counting BM Blasts

Leukemia research, 2017-04, Vol.55, p.S4-S4

2017

Volltextzugriff (PDF)

O12 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: CLINICAL OUTCOMES AND MOLECULAR PROFILE OF OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA SUPPORT ITS CONSIDERATION AS THE FIRST STEP IN THE PROLIFERATIVE CONTINUUM OF CHRONIC MYELOMONOCYTIC LEUKEMIA

Leukemia research, 2021-09, Vol.108

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

Choosing the Appropriate Denominator for Counting BM Blasts

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome

Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale

The Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts can be Improved by Considering Bone Marrow Blasts from Nonerythroid Cells

Clinical and Biological Significance of Y Chromosome Loss in a Series of 2,423 Male Patients with MDS and CMML

Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance

Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT

260 CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS

261 ERYTHROLEUKEMIA APPEARS TO BE A CONTINUUM OF MDS WITH ERYTHROID HYPERPLASIA AND SHARES OUTCOME AND CYTOGENETIC FEATURES WITH RAEB-1 WITH ≥50% ERYTHROPOIESIS

144 CSF3R POINT MUTATIONS IN A COHORT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND NEUTROPENIA AT DIAGNOSIS

Prognostic Impact of Circulating Plasma Cells on Survival of Patients With Multiple Myeloma

Smoldering Multiple Myeloma: Impact of the Evolving Pattern on Early Progression

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

P368 Correlation between patient-reported outcome measures in inflammatory bowel disease and other measures of disease activity: a systematic review

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

313 Clinical features and prognostic significance of monosomal karyotype (MK) in the myelodysplastic syndromes (MDS)

Validation of the ATTR-CM score for transthyretin amyloid cardiomiopathy in a mediterranean cohort of patients at risk

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior

O-056 - ANÁLISIS DESCRIPTIVO DE LOS EVENTOS TROMBOEMBÓLICOS VENOSOS EN PACIENTES INGRESADOS EN NEUROCIRUGÍA DESDE EL INICIO DE LA ASISTENCIA COMPARTIDA

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: GENOMIC DETERMINANTS OF DYSMYELOPOIESIS AND EVALUATION OF ITS PROGNOSTIC IMPACT IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SEX DETERMINES DIFFERENTIAL GENOMIC PROFILES IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) INVOLVING UNDERREPRESENTATION OF SRSF2 GENE MUTATION

8 - Choosing the Appropriate Denominator for Counting BM Blasts

O12 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: CLINICAL OUTCOMES AND MOLECULAR PROFILE OF OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA SUPPORT ITS CONSIDERATION AS THE FIRST STEP IN THE PROLIFERATIVE CONTINUUM OF CHRONIC MYELOMONOCYTIC LEUKEMIA

Suchergebnisse filtern